NeuroOne Medical Technologies Corporation (NMTC)

NMTC Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 7, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Capitalization	46	44	31	21	27	47
Market Cap Growth	102.77%	45.65%	43.23%	-22.25%	-42.21%	66.31%
Enterprise Value	43	37	29	18	17	39
Last Close Price	0.98	0.89	0.99	0.89	1.69	3.95
PS Ratio	3.25	3.67	8.83	6.25	12.92	195.11
PB Ratio	6.93	6.28	37.11	3.41	2.85	7.23
P/TBV Ratio	7.03	6.32	40.42	3.46	2.89	7.38
EV/Sales Ratio	3.56	3.03	8.45	5.41	8.23	159.21
Debt / Equity Ratio	0.04	0.04	0.32	0.03	0.02	0.05
Asset Turnover	1.50	1.50	0.51	0.33	0.20	0.04
Inventory Turnover	3.68	3.68	3.41	6.94	12.88	-
Quick Ratio	3.40	3.40	0.74	2.97	3.61	5.88
Current Ratio	4.44	4.44	2.09	4.08	3.93	6.17
Return on Equity (ROE)	-91.34%	-91.34%	-348.39%	-149.61%	-123.77%	-230.81%
Return on Assets (ROA)	-32.70%	-32.70%	-110.33%	-71.43%	-60.39%	-100.59%
Return on Capital (ROIC)	-62.73%	-62.73%	-197.70%	-92.01%	-75.19%	-123.55%
Return on Capital Employed (ROCE)	-49.80%	-49.80%	-376.60%	-189.60%	-103.20%	-151.20%
Earnings Yield	-7.29%	-8.12%	-40.38%	-55.68%	-36.50%	-20.99%
FCF Yield	-5.91%	-6.57%	-36.49%	-62.31%	-28.46%	-18.29%
Buyback Yield / Dilution	-50.03%	-50.03%	-47.69%	-13.27%	-49.56%	-97.52%

Updated Dec 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q